Your patients’ health is your top priority. Better understand your patient’s genes and how they may impact their medications. Genelex, a leader in the field of molecular diagnostics and genetics laboratory testing for more than 30 years, in conjunction with a leading clinical decision support tool (CDST), may help you bring more effective medication management especially for high risk polypharmacy patients. The CDST was inspired by a healthcare provider who wanted to establish a more automated and precise medication management system to enhance patient care.

Genelex is a leader in precision medication management. A pioneer in DNA testing since 1987, Genelex now focuses exclusively on pharmacogenetic testing. Backed by a powerful combination of innovative analytics software, state-of art laboratory facilities, and expert staff, Genelex has a longstanding commitment to the prevention of dangerous and life-threatening adverse drug events (ADEs).

2bPrecise delivers transformative point-of-care solutions that serve as the foundation for scalable precision medicine success.

Precision medicine is rewriting the rules of health care. And 2bPrecise is rewriting the rules of precision medicine. Representing decades of deep clinical knowledge and award-winning technology, our 2bPrecise platform heavy-lifts vast amounts of the data you need, then simplifies, condenses and extracts it. The result? Integrated, actionable genomic information delivered directly into your workflow and harmonized with existing patient data – in any EHR. Plus, semantically stored, research-ready data that can be accessed and acted upon for later study – as science evolves. That’s a powerful set of clinical decision-making tools, in your hands – at the point of care.